Anturane Reinfarction Trial Research Group (1980). Sulfinpyrazone in the prevention of sudden death after myocardial infarction. New England Journal of Medicine 302:250–256Google Scholar

Asymptomatic Carotid Atherosclerosis Study Group (1995). Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosis. Journal of the American Medical Association 273:1421–1428Google Scholar

Barnett, HJ, Taylor, DW, Eliasziw, M et al. (1998). The final results of the NASCET trial. New England Journal of Medicine 339:1415–1425CrossRefGoogle Scholar

Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989). Preliminary report: Effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction. New England Journal of Medicine 321:406–412CrossRefGoogle Scholar

Charlson, ME, Horwitz, RI (1984). Applying results of randomised trials to clinical practice: Impact of losses before randomisation. British Medical Journal 289:1281–1284CrossRefGoogle ScholarPubMed

Coronary Drug Project Research Group (1980). Influence of adherence to treatment and response to cholesterol on mortality in the Coronary Drug Project. New England Journal of Medicine 303:1038–1041CrossRefGoogle Scholar

Dahlof, B, Lindholm, LH, Hansson, L et al. (1991). Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 338:1281–1285Google Scholar

Davis, KL, Thal, LJ, Gamzu, ER et al. (1992). A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer’s disease. New England Journal of Medicine 321:406–412Google Scholar

Farrell, B, Godwin, J, Richards, S et al. (1991). The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Final results. Journal of Neurology, Neurosurgery and Psychiatry 54:1044–1054Google Scholar

Fine, PEM (1995). Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346:1339–1345Google Scholar

Gorter, JW for the Stroke Prevention in Reversible Ischaemia Trial (SPIRIT) and European Atrial Fibrillation Trial (EAFT) Groups (1999). Major bleeding during anticoagulation after cerebral ischaemia: Patterns and risk factors. Neurology 53:1319–1327Google Scholar

Gøtzsche, PC (1989). Methodology and overt and hidden bias in reports of 196 double-blind trials of nonsteroidal antiinflammatory drugs in rheumatoid arthritis. Control in Clinical Trials 10:31–56Google Scholar

Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI) (1986). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet i:397–402Google Scholar

Gurwitz, JH, Col, NF, Avorn, J (1992). The exclusion of elderly and women from clinical trials in acute myocardial infarction. Journal of the American Medical Association 268:1417–1422Google Scholar

Ioannidis, JP, Contopoulos-Ioannidis, DG (1998). Reporting of safety data from randomised trials. Lancet 352:1752–1753Google Scholar

Jorgensen, HS, Nakayama, H, Kammersgaard, LP et al. (1999). Predicted impact of intravenous thrombolysis on prognosis of general population of stroke patients: Simulation model. British Medical Journal 319:288–289Google Scholar

LaRue, LJ, Alter, M, Traven, ND et al. (1988). Acute stroke therapy trials: Problems in patient accrual. Stroke 19:950–954CrossRefGoogle ScholarPubMed

Marshall, M, Lockwood, A, Bradley, C et al. (2000). Unpublished rating scales: A major source of bias in randomised controlled trials of treatments for schizophrenia? British Journal of Psychiatry 176:249–252CrossRefGoogle Scholar

Medical Research Council Working Party (1985). MRC trial of treatment of mild hypertension: Principal results. British Medical Journal 291:97–104Google Scholar

Noseworthy, JH, Ebers, GC, Vandervoort, MK et al. (1994). The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology 44:16–20Google Scholar

Pincus, T (1998). Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials. Journal of Clinical Epidemiology 41:1037–1041Google Scholar

Riggs, BL, Hodgson, SF, O’Fallon, WM et al. (1990). Effect of fluoride treatment on fracture rate in postmenopausal women with osteoporosis. New England Journal of Medicine 322:802–809Google Scholar

Rothwell, PM (2005a). External validity of randomised controlled trials: To whom do the results of this trial apply? Lancet 365:82–93Google Scholar

Rothwell, PM (2005b). Subgroup analysis in randomised controlled trials: Importance, indications and interpretation. Lancet 365:176–186Google Scholar

Rothwell, PM, Warlow, CP (1995). Is self-audit reliable? Lancet 346:1623Google Scholar

Rothwell, PM, Giles, MF, Chandratheva, A et al. (2007). Major reduction in risk of early recurrent stroke by urgent treatment of TIA and minor stroke: EXPRESS Study. Lancet 370:1432–1442Google Scholar

Shapiro, SH, Weijer, C, Freedman, B (2000). Reporting the study populations of clinical trials. Clear transmission or static on the line? Journal of Clinical Epidemiology 53:973–979Google Scholar

Taylor, DW, Barnett, HJM, Haynes, RB et al. (1999). Low dose and high dose acetylsalicylic acid for patients undergoing carotid endarterectomy: A randomised controlled trial. Lancet 353:2179–2184CrossRefGoogle ScholarPubMed

Temple, R, Pledger, GW (1980). The FDA’s critique of the Anturane Reinfarction Trial. New England Journal of Medicine 303:1488–1492Google Scholar

Thornley, B, Adams, CE (1998). Content and quality of 2000 controlled trials in schizophrenia over 50 years. British Medical Journal 317:1181–1184CrossRefGoogle ScholarPubMed

Amarenco, P, Bogousslavsky, J, Callahan, A III for the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators (2006). High-dose atorvastatin after stroke or transient ischemic attack. New England Journal of Medicine 355:549–559Google Scholar

Amarenco, P, Albers, GW, Denison, H et al. (2017). Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischemic attack of atherosclerotic origin: A subgroup analysis of SOCRATES, a randomized, double-blind, controlled trial. Lancet Neurology 16:301–310CrossRefGoogle ScholarPubMed

Antithrombotic Trialists Collaboration (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. British Medical Journal 324:71–86Google Scholar

Bath, PM, Robson, K, Woodhouse, LJ et al. (2015). Statistical analysis plan for the ‘Triple Antiplatelets for Reducing Dependency after Ischemic Stroke’ (TARDIS) trial. International Journal of Stroke 10:449–451Google Scholar

Bath, PM, Woodhouse, LJ, Appleton, JP et al. (2017). Antiplatelet therapy with aspirin, clopidogrel, and dipyridamole versus clopidogrel alone or aspirin and dipyridamole in patients with acute cerebral ischemic (TARDIS): A randomized, open-label, phase 3 superiority trial. Lancet. doi:10.1016/S0140-6736(17)32849-0 [Epub ahead of print]Google Scholar

Burke, JF, McDermott, M (2016). Pursuing “model care” of transient ischemic attacks. Neurology 86:888–889Google Scholar

CAPRIE Steering Committee (1996). A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329–1339CrossRefGoogle Scholar

Carroll, C, Hobart, J, Fox, C et al. (2004). Stroke in Devon: Knowledge was good, but action was poor. Journal of Neurology, Neurosurgery and Psychiatry 75:567–571Google Scholar

Castaldo, JE, Nelson, JJ, Reed, JF III et al. (1997). The delay in reporting symptoms of carotid artery stenosis in an at-risk population. The Asymptomatic Carotid Atherosclerosis Study experience: A statement of concern regarding watchful waiting. Archives of Neurology 54:1267–1271Google Scholar

Chandratheva, A, Lasserson, DS, Geraghty, OC et al. (2010a). Population-based study of behavior immediately after transient ischemic attack and minor stroke in 1000 consecutive patients: Lessons for public education. Stroke 41:1108–1114CrossRefGoogle ScholarPubMed

Chandratheva, A, Geraghty, OC, Luengo-Fernandez, R et al. (2010b). ABCD² score predicts severity rather than risk of early recurrent events after transient ischemic attack. Stroke 41:851–856CrossRefGoogle ScholarPubMed

Diener, HC, Cunha, L, Forbes, C et al. (1996). European secondary prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. Journal of Neurology Science 143:1–13Google Scholar

Evenson, KR, Rosamond, WD, Morris, DL (2001). Prehospital and in-hospital delays in acute stroke care. Neuroepidemiology 20:65–76CrossRefGoogle ScholarPubMed

Giles, MF, Flossman, E, Rothwell, PM (2006). Patient behaviour immediately after transient ischemic attack according to clinical characteristics, perception of the event, and predicted risk of stroke. Stroke 37:1254–1260Google Scholar

Hackam, DG, Spence, JD (2007). Combining multiple approaches for the secondary prevention of vascular events after stroke: A quantitative modeling study. Stroke 38:1881–1885Google Scholar

Halkes, PH, van Gijn, J for the ESPRIT Study Group (2006). Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): Randomised controlled trial. Lancet 367:1665–1673Google Scholar

Harraf, F, Sharma, AK, Brown, MM et al. (2002). A multicentre observational study of presentation and early assessment of acute stroke. British Medical Journal 325:17–22Google Scholar

Hart, RG, Pearce, LA, Aguilar, MI (2007). Meta-analysis: Antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Annals of Internal Medicine 146:857–867Google Scholar

Huang, Y, Cheng, Y, Wu, J et al. (2008). Cilostazol as an alternative to aspirin after ischemic stroke: A randomized, double-blind, pilot study. Lancet Neurology 7:494–499Google Scholar

Husted, S, Emanuelsson, H, Heptinstall, S et al. (2006). Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: A double-blind comparison to clopidogrel with aspirin. European Heart Journal 27:1038–1047CrossRefGoogle ScholarPubMed

Johnston, SC, Fayad, PB, Gorelick, PB et al. (2003). Prevalence and knowledge of transient ischemic attack among US adults. Neurology 60:1429–1434Google Scholar

Johnston, SC, Nguyen-Huynh, MN, Schwarz, ME et al. (2006). National Stroke Association guidelines for the management of transient ischemic attacks. Annals of Neurology 60:301–313Google Scholar

Johnston, SC, Rothwell, PM, Nguyen-Huynh, MN et al. (2007). Validation and refinement of scores to predict very early stroke risk after transient ischaemic attack. Lancet 369:283–292Google Scholar

Johnston, SC, Easton, JD, Farrant, M et al. (2013). Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: Rationale and design. International Journal of Stroke 8:479–483Google Scholar

Johnston, SC, Amarenco, P, Albers, GW et al. (2016). Ticagrelor versus aspirin in acute stroke or transient ischemic attack. New England Journal of Medicine 375:35–43Google Scholar

Joshi, JK, Ouyang, B, Prabhakaran, S (2011). Should TIA patients be hospitalized or referred to a same-day clinic?: A decision analysis. Neurology 77:2082–2088Google Scholar

Kennedy, J, Hill, MD, Ryckborst, KJ et al. (2007). Fast Assessment of Stroke and Transient Ischaemic Attack to Prevent Early Recurrence (FASTER): A randomised controlled pilot trial. Lancet Neurology 6:961–969Google Scholar

Kernan, WN, Ovbiagele, B, Black, HR et al. (2014). Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 45:2160–2236Google Scholar

Kidwell, CS, Starkman, S, Eckstein, M et al. (2000). Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 31:71–76Google Scholar

Kothari, RU, Pancioli, A, Liu, T et al. (1999). Cincinnati Prehospital Stroke Scale: Reproducibility and validity. Annals of Emergency Medicine 33:373–378Google Scholar

Lacy, CR, Suh, DC, Bueno, M et al. (2001). Delay in presentation and evaluation for acute stroke: Stroke Time Registry for Outcomes Knowledge and Epidemiology (STROKE). Stroke 32:63–69Google Scholar

Lavallée, PC, Meseguer, E, Abboud, H et al. (2007). A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): Feasibility and effects. Lancet Neurology 6:953–960CrossRefGoogle ScholarPubMed

Lecouturier, J, Murtagh, MJ, Thomson, RG et al. (2010). Response to symptoms of stroke in the UK: A systematic review. BMC Health Services Research 10:157Google Scholar

Liu, L, Wang, Z, Gong, L et al. (2009). Blood pressure reduction for the secondary prevention of stroke: A Chinese trial and a systematic review of the literature. Hypertension Research 32:1032–1040Google Scholar

National Institute for Health and Clinical Excellence (2017). Stroke and Transient Ischemic Attack in Over 16s: Diagnosis and Initial Management. London: NICEGoogle Scholar

Nedeltchev, K, Fischer, U, Arnold, M et al. (2007). Low awareness of transient ischemic attacks and risk factors of stroke in a Swiss urban community. Journal of Neurology 254:179–184Google Scholar

Nor, A, Mc Allister, C, Louw, S et al. (2004). Agreement between ambulance paramedicand physician-recorded neurological signs using the Face Arm Speech Test (FAST) in acute stroke patients. Stroke 35:1355–1359Google Scholar

Nor, AM, Davis, J, Sen, B et al. (2005). The Recognition of Stroke in the Emergency Room (ROSIER) scale: Development and validation of a stroke recognition instrument. Lancet Neurology 4:727–734Google Scholar

Olivot, JM, Wolford, C, Castle, J et al. (2011). Two aces: Transient ischemic attack work-up as outpatient assessment of clinical evaluation and safety. Stroke 42:1839–1843CrossRefGoogle ScholarPubMed

Pancioli, A, Broderick, J, Kothari, R et al. (1998). Public perception of stroke warning signs and knowledge of potential risk factors. Journal of the American Medical Association 279:1288–1292Google Scholar

Parahoo, K, Thompson, K, Cooper, M et al. (2003). Stroke: Awareness of the signs, symptoms and risk factors – a population-based survey. Cerebrovascular Diseases 16:134–140Google Scholar

Ranta, A, Dovey, S, Weatherall, M et al. (2015). Cluster randomized controlled trial of TIA electronic decision support in primary care. Neurology 84:1545–1551Google Scholar

Ranta, A, Barber, PA (2016). Transient ischemic attack service provision: A review of available service models. Neurology 86:947–953Google Scholar

Reeves, MJ, Hogan, JG, Rafferty, AP (2002). Knowledge of stroke risk factors and warning signs among Michigan adults. Neurology 59:1547–1552Google Scholar

Rothwell, PM, Gutnikov, SA, Eliasziw, M for the Carotid Endarterectomy Trialists’ Collaboration (2003). Pooled analysis of individual patient data from randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet 361:107–116Google Scholar

Rothwell, PM, Eliasziw, M, Gutnikov, SA for the Carotid Endarterectomy Trialists Collaboration (2004a). Effect of endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and to the timing of surgery. Lancet 363:915–924Google Scholar

Rothwell, PM, Coull, A, Giles, MF for the Oxford Vascular Study (2004b). Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 363:1925–1933Google Scholar

Rothwell, PM, Giles, MF, Flossman, E et al. (2005). A simple score (ABCD) to identify individuals at high early risk of stroke after transient ischaemic attack. Lancet 366:29–36Google Scholar

Rothwell, PM, Giles, MF, Chandratheva, A et al. (2007). Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): A prospective population-based sequential comparison. Lancet 370:1432–1442CrossRefGoogle ScholarPubMed

Rothwell, PM, Algra, A, Chen, Z et al. (2016). Effects of aspirin on risk and severity of early recurrent stroke after transient ischemic attack and ischemic stroke: Time-course analysis of randomized trials. Lancet 388:365–375Google Scholar

Ruff, CT, Giugliano, RP, Braunwald, E et al. (2014). Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomized trials. Lancet 383:955–962Google Scholar

Salisbury, HR, Banks, BJ, Footitt, DR et al. (1998). Delay in presentation of patients with acute stroke to hospital in Oxford. Quarterly Journal of Medicine 97:635–640Google Scholar

Sanders, LM, Srikanth, VK, Jolley, DJ et al. (2012). Monash transient ischemic attack triaging treatment: Safety of a transient ischemic attack mechanism-based outpatient model of care. Stroke 43:2936–2941Google Scholar

Shinohara, Y, Katayama, Y, Uchiyama, S et al. (2010). Cilostazol for prevention of secondary stroke (CSPS 2): An aspirin-controlled, double-blind, randomized non-inferiority trial. Lancet Neurology 9:959–968Google Scholar

Smith, MA, Doliszny, KM, Shahar, E et al. (1998). Delayed hospital arrival for acute stroke: The Minnesota Stroke Survey. Annals of International Medicine 129:190–196Google Scholar

Storey, RF, Husted, S, Harrington, RA et al. (2007). Inhibition of platelet aggregation by AZD6140, a reversible oral P2Y12 receptor antagonist, compared with clopidogrel in patient with acute coronary syndromes. Journal of American College of Cardiology 50:1852–1856Google Scholar

Wang, Y Wang, Y, Zhao, X et al. (2013). Clopidogrel with aspirin in acute minor stroke or transient ischemic attack. New England Journal of Medicine 369:11–19CrossRefGoogle ScholarPubMed

Wasserman, J, Perry, J, Dowlatshahi, D et al. (2010). Stratified, urgent care for transient ischemic attack results in low stroke rates. Stroke 41:2601–2605CrossRefGoogle ScholarPubMed

Wolters, FJ, Paul, NL, Li, L et al. (2015). Sustained impact of UK FAST-test public education on response to stroke: A population-based time-series study. International Journal of Stroke 10:1108–1114Google Scholar

Wong, KS, Wang, Y, Leng, X et al. (2013). Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: An updated systematic review and meta-analysis. Circulation 128:1656–1666Google Scholar

Andre, C, de Freitas, GR, Fukujima, MM (2007). Prevention of deep venous thrombosis and pulmonary embolism following stroke: A systematic review of published articles. European Journal of Neurology 14:21–32Google Scholar

Barrett, JA (2001). Bladder and bowel problems after a stroke. Reviews in Clinical Gerontology 12:253–267Google Scholar

Bath, FJ, Bath, PMW (1997). What is the correct management of blood pressure in acute stroke? The Blood Pressure in Acute Stroke Collaboration. Cerebrovascular Diseases 7:205–213Google Scholar

Bath, PM, Krishnan, K (2014). Interventions for deliberately altering blood pressure in acute stroke. Cochrane Database of Systematic Reviews 10:CD000039Google Scholar

Bath, PM, Woodhouse, L, Scutt, P et al. (2015). Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): A partial-factorial randomized controlled trial. Lancet 385:617–628Google Scholar

Bellolio, MF, Gilmore, RM, Ganti, L (2014). Insulin for glycemic control in acute ischemic stroke. Cochrane Database of Systematic Reviews 1:CD005346Google Scholar

Bernhardt, J, Langhorne, P, Lindley, RI et al. (2015). Efficacy and safety of very early mobilization within 24 h of stroke onset (AVERT): A randomized controlled trial. Lancet 386:46–55Google Scholar

Bhogal, SK, Teasell, R, Foley, N et al. (2004). Lesion location and poststroke depression: Systematic review of the methodological limitations in the literature. Stroke 35:794–802CrossRefGoogle ScholarPubMed

Bray, BD, Ayis, S, Campbell, J et al. (2013). Associations between the organization of stroke services, process of care, and mortality in England: Prospective cohort study. British Medical Journal 346:f2827Google Scholar

Bruno, A, Durkalski, VL, Hall, CE et al. (2014). The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial protocol: A randomized, blinded, efficacy trial of standard vs. intensive hyperglycemia management in acute stroke. International Journal of Stroke 9:246–251Google Scholar

Carota, A, Berney, A, Aybek, S et al. (2005) A prospective study of predictors of poststroke depression. Neurology 64:428–433Google Scholar

Chan, EY, Ruest, A, Meade, MO et al. (2007) Oral decontamination for prevention of pneumonia in mechanically ventilated adults: Systematic review and meta-analysis. British Medical Journal 334:889–893Google Scholar

CLOTS Trials Collaboration (2009). Effectiveness of thigh-length graduated compression stockings to reduce the risk of deep vein thrombosis after stroke (CLOTS trial 1): A multicenter, randomized controlled trial. Lancet 373:1958–1965Google Scholar

CLOTS Trials Collaboration (2014). Effect of intermittent pneumatic compression on disability, living circumstances, quality of life, and hospital costs after stroke: Secondary analyses from CLOTS 3, a randomized trial. Lancet Neurology 13:1186–1192Google Scholar

Cook, DJ, Reeve, BK, Guyatt, GH et al. (1996). Stress ulcer prophylaxis in critically ill patients. Resolving discordant meta-analyses. JAMA 275:308–314Google Scholar

Davenport, RJ, Dennis, MS, Wellwood, I et al. (1996a). Complications after acute stroke. Stroke 27:415–420Google Scholar

Davenport, RJ, Dennis, MS, Warlow, CP (1996b). Gastrointestinal hemorrhage after acute stroke. Stroke 27:421–424Google Scholar

de Ridder, IR, de Jong, FJ, den Hertog, HM et al. (2015). Paracetamol (Acetaminophen) in stroke 2 (PAIS 2): Protocol for a randomized, placebo-controlled, double-blind clinical trial to assess the effect of high-dose paracetamol on functional outcome in patients with acute stroke and a body temperature of 36.5°C or above. International Journal of Stroke 10:457–462Google Scholar

den Hertog, HM, van der Worp, HB, Tseng, MC et al. (2009a). Cooling therapy for acute stroke. Cochrane Database of Systematic Reviews 1:CD001247Google Scholar

den Hertog, HM, van der Worp, HB, van Gemert, HM et al. (2009b). The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: A multicenter, randomized, placebo-controlled, phase III trial. Lancet Neurology 8:434: 440Google Scholar

Dennis, MS, Lewis, SC, Warlow, C et al. (2005). Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): A multicentre randomised controlled trial. Lancet 365:764–772Google Scholar

Frese, A, Husstedt, IW, Ringelstein, EB et al. (2006). Pharmacologic treatment of central post-stroke pain. Clinical Journal of Pain 22:252–260Google Scholar

Fuentes, B, Diez-Tejedor, E, Ortega-Casarrubios, MA et al. (2006). Consistency of the benefits of stroke units over years of operation: An 8-year effectiveness analysis. Cerebrovascular Diseases 21:173–179Google Scholar

Geeganage, CM, Sprigg, N, Bath, MW et al. (2013). Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: A systematic review and meta-analysis of randomized controlled trials. Journal of Stroke and Cerebrovascular Diseases 22:1018–1027Google Scholar

Gelber, DA, Good, DC, Laven, LJ et al. (1993). Causes of urinary incontinence after acute hemispheric stroke. Stroke 24:378–382Google Scholar

Hackett, ML, Anderson, CS (2005). Predictors of depression after stroke: A systematic review of observational studies. Stroke 36:2296–2301Google Scholar

Hackett, ML, Yapa, C, Parag, V et al. (2005). Frequency of depression after stroke: A systematic review of observational studies. Stroke 36:1330–1340Google Scholar

Hackett, ML, Anderson, CS, House, A et al. (2008). Interventions for treating depression after stroke. Cochrane Database of Systematic Reviews 8:CD003437Google Scholar

Hamdy, S, Aziz, Q, Rothwell, JC et al. (1997). Explaining oropharyngeal dysphagia after unilateral hemispheric stroke. Lancet 350:686–692Google Scholar

Hankey, GJ (2017). Stroke. Lancet 389:641–654Google Scholar

Hesami, O, Gharagozli, K, Beladimoghadam, N et al. (2015). The efficacy of gabapentin in patients with central post-stroke pain. Iranian Journal of Pharmaceutical Research 14:95–101Google Scholar

Hilker, R, Poetter, C, Findeisen, N et al. (2003). Nosocomial pneumonia after acute stroke: Implications for neurological intensive care medicine. Stroke 34:975–981Google Scholar

Hinds, NP, Wiles, CM (1998). Assessment of swallowing and referral to speech and language therapists in acute stroke. Quarterly Journal of Medicine 91:829–835Google Scholar

Hsu, HL, Lin, YH, Huang, YC et al. (2009). Gastrointestinal hemorrhage after acute ischemic stroke and its risk factors in Asians. European Neurology 62:212–218Google Scholar

Indredavik, B, Rohweder, G, Naalsund, E et al. (2008). Medical complications in a comprehensive stroke unit and an early supported discharge service. Stroke 39:414–420Google Scholar

Intercollegiate Working Party on Stroke (2010). National Sentinel Audit. London: Royal College of Physicians.Google Scholar

Kalra, L, Irshad, S, Hodsoll, J et al. (2015). Prophylactic antibiotics after acute stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): A prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 386:1835–1844Google Scholar

Katzan, IL, Cebul, RD, Husak, SH et al. (2003). The effect of pneumonia on mortality among patients hospitalized for acute stroke. Neurology 60:620–625Google Scholar

Kim, JS, Bashford, G, Murphy, TK et al. (2011). Safety and efficacy of pregabalin in patients with central post-stroke pain. Pain 152:1018–1023Google Scholar

Kobayashi, H, Hoshino, M, Okayama, K et al. (1994). Swallowing and cough reflexes after onset of stroke. Chest 105:1623Google Scholar

Kumar, S, Selim, MH and Caplan, LR (2010). Medical complications after stroke. Lancet Neurology 9:105–108Google Scholar

Jauch, EC, Saver, JL, Adams, HP Jr. et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947Google Scholar

Jönsson, AC, Lindgren, I, Hallström, B et al. (2006). Prevalence and intensity of pain after stroke: A population based study focusing on patients’ perspectives. Journal of Neurology, Neurosurgery and Psychiatry 77:590–595Google Scholar

Leijon, G, Boivie, J (1989). Central poststroke pain – a controlled trial of amitriptyline and carbamazepine. Pain 36:27–36Google Scholar

Mari, F, Matei, M, Ceravolo, MG et al. (1997). Predictive value of clinical indices in detecting aspiration in patients with neurological disorders. Journal of Neurology, Neurosurgery and Psychiatry 63:456–460CrossRefGoogle ScholarPubMed

Martino, R, Foley, N, Bhogal, S et al. (2005). Dysphagia after stroke: Incidence, diagnosis, and pulmonary complications. Stroke 36:2756–2763Google Scholar

Mead, GE, Hsieh, CF, Lee, R et al. (2012). Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Systematic Reviews 11:CD009286Google Scholar

Moodie, M, Cadilhac, D, Pearce, D et al. (2006). SCOPES Study Group. Economic evaluation of Australian stroke services: A prospective multicenter study comparing dedicated stroke units with other care modalities. Stroke 37:2790–2795CrossRefGoogle Scholar

Nakayama, H, Jorgensen, HS, Pedersen, PM et al. (1997). Prevalence and risk factors of incontinence after stroke. Stroke 28:58–62Google Scholar

Nasreddine, ZS, Saver, JL (1997). Pain after thalamic stroke: Right diencephalic predominance and clinical features in 180 patients. Neurology 48:1196–1199Google Scholar

National Institute for Health and Care Excellence (2014). Pressure ulcers: Pressure and management. Clinical guideline [CG179]Google Scholar

O’Donnell, MJ, Kapral, MK, Fang, J et al. (2008). Gastrointestinal bleeding after acute ischemic stroke. Neurology 71:650–655Google Scholar

Oppenheimer, SM, Cechetto, DF, Hachinski, VC (1990). Cerebrogenic cardiac arrhythmias. Cerebral electrocardiographic influences and their role in sudden death. Archives of Neurology 47:513–519Google Scholar

Patel, M, Coshall, C, Rudd, AG et al. (2001). Natural history and effects on 2-year outcomes of urinary incontinence after stroke. Stroke 32:122–127Google Scholar

Patel, A, Knapp, M, Evans, A et al. (2004). Training care givers of stroke patients: Economic evaluation. British Medical Journal 328:1102Google Scholar

Prosser, J, MacGregor, L, Lees, KR et al. (2007). Predictors of early cardiac morbidity and mortality after ischemic stroke. Stroke 38:2295–2302Google Scholar

Reith, J, Jorgensen, HS, Pedersen, PM et al. (1996). Body temperature in acute stroke: Relation to stroke severity, infarct size, mortality and outcome. Lancet 347:422–425Google Scholar

Roffe, C, Nevatte, T, Crome, P et al. (2014). The Stroke Oxygen Study (SO₂S) – a multi-center study to assess whether routine oxygen treatment in the first 72 hours after a stroke improves long-term outcome: Study protocol for a randomized controlled trial. Trials 15:99Google Scholar

Rothwell, PM, Algra, A, Chen, Z et al. (2016). Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: Time-course analysis of randomized trials. Lancet 388:365–375Google Scholar

Rowat, AM, Dennis, MS, Wardlaw, JM (2006). Hypoxemia in acute stroke is frequent and worsens outcome. Cerebrovascular Diseases 21:166–172CrossRefGoogle ScholarPubMed

Sandercock, PA, Counsell, C, Tseng, MC et al. (2014). Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database of Systematic Reviews 3:CD000029Google Scholar

Santesso, N, Carrasco-Labra, A, Brignardello-Petersen, R (2014). Hip protectors for preventing hip fractures in older people. Cochrane Database of Systematic Reviews 3:CD001255Google Scholar

Sato, Y, Kuno, H, Kaji, M et al. (1998). Increased bone resorption during the first year after stroke. Stroke 29:1373–1377Google Scholar

Sellars, C, Bowie, L, Bagg, J et al. (2007). Risk factors for chest infection in acute stroke: A prospective cohort study. Stroke 38:2284–2291Google Scholar

Sörös, P, Hachinski, V (2012). Cardiovascular and neurological causes of sudden death after ischaemic stroke. Lancet Neurology 11:179–188Google Scholar

Stroke Unit Trialists’ Collaboration (2013). Organised inpatient (stroke unit) care for stroke. Cochrane Database of Systematic Reviews 9:CD000197Google Scholar

Sulter, G, Elting, JW, Stewart, R et al. (2000). Continuous pulse oximetry in acute hemiparetic stroke. Journal of the Neurological Sciences 179:65–69Google Scholar

Thomas, LH, Cross, S, Barrett, J, et al. (2008). Treatment of urinary incontinence after stroke in adults. Cochrane Database of Systematic Reviews 1:CD004462Google Scholar

Touzé, E, Varenne, O, Chatellier, G et al. (2005). Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: A systematic review and meta-analysis. Stroke 36:2748–2755Google Scholar

van der Worp, HB, Kappelle, LJ (1998). Complications of acute ischemic stroke. Cerebrovascular Diseases 8:124–132Google Scholar

Vestergaard, K, Andersen, G, Gottrup, H et al. (2001). Lamotrigine for central poststroke pain: A randomized controlled trial. Neurology 56:184–190Google Scholar

Westendorp, WF, Vermeij, JD, Zock, E, et al. (2015). The Preventive Antibiotics in Stroke Study (PASS): A pragmatic randomized open-label masked endpoint clinical trial. Lancet 385:1519–1526Google Scholar

Yoneyama, T, Yoshida, M, Matsui, T et al. (1999). Oral care and pneumonia. Oral Care Working Group. Lancet 354:515Google Scholar

Albers, GW, von Kummer, R, Truelsen, T et al. (2015) Safety and efficacy of desmoteplase given 3–9 h after ischemic stroke in patients with occlusion or high-grade stenosis in major cerebral arteries (DIAS-3): A double-blind, randomized, placebo-controlled phase 3 trial. Lancet Neurology 14:575–584Google Scholar

Albers, GW, Marks, MP, Kemp, S et al. (2018). Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging. New England Journal of Medicine 378:708–718Google Scholar

Anderson, CS, Robinson, T, Lindley, RI et al. (2016). Low-dose versus standard-dose intravenous alteplase in acute ischemic stroke. New England Journal of Medicine 374:2313–2323Google Scholar

Berge, E (2007). Heparin for acute ischemic stroke: A never-ending story? Lancet Neurology 6:381–382CrossRefGoogle Scholar

Berge, E, Cohen, G, Roaldsen, MB et al. (2016). Effects of alteplase on survival after ischemic stroke (IST-3): 3 year follow-up of a randomized, controlled, open-label trial. Lancet Neurology 15:1028–1034Google Scholar

Berkhemer, OA, Fransen, PS, Beumer, D et al. (2015). A randomized trial of intraarterial treatment for acute ischemic stroke. New England Journal of Medicine 372:11–20Google Scholar

Bernard, SAGT, Buist, MD, Jones, BM et al. (2002). Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. New England Journal of Medicine 346:557–563Google Scholar

Bhatia, R, Hill, MD, Shobha, N et al. (2010). Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: Real-world experience and a call for action. Stroke 41:2254–2258Google Scholar

Broderick, JP, Palesch, YY, Demchuck, AM et al. (2013). Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. New England Journal of Medicine. 368:893–903Google Scholar

Brott, TG, Haley, EC Jr., Levy, DE et al. (1992). Urgent therapy for stroke. Part I. Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23:632–640Google Scholar

Campbell, BC, Mitchell, MJ, Kleinig, TJ et al. (2015). Endovascular therapy for ischemic stroke with perfusion-imaging selection. New England Journal of Medicine 372:1009–1018Google Scholar

Chinese Acute Stroke Trial (CAST) Collaborative Group (1997). CAST: Randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischemic stroke. Lancet 349:1641–1649Google Scholar

Ciccone, A, Valvassori, L, Nichelatti, M et al. (2013). Endovascular treatment for acute ischemic stroke. New England Journal of Medicine 368:904–913Google Scholar

Clark, WM, Wissman, S, Albers, GW et al. (1999). Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: A randomized controlled trial. Alteplase Thrombolysis for acute Noninterventional Therapy in Ischemic Stroke. JAMA 282:2019–2026Google Scholar

Collen, D. (1987) Molecular mechanisms of fibrinolysis and their application to fibrin-specific thrombolytic therapy. Journal of Cellular Biochemistry 33:77–86Google Scholar

Connolly, SJ, Milling, TJ Jr., Eikelboom, JW et al. (2016). Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. New England Journal of Medicine 375:1131–1141Google Scholar

Davis, SM, Donnan, GA, Parsons, MW et al. (2008) Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): A placebo-controlled randomized trial. Lancet Neurology 7:299–309Google Scholar

del Zoppo, GJ, Higashida, RT, Furlan, AJ et al. (1998). PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT Investigators Prolyse in Acute Cerebral Thromboembolism. Stroke 29:4–11Google Scholar

Demaerschalk, BM, Kleindorfer, DO, Adeoye, OM et al. (2016). Scientific rationale for the inclusion and exclusion criteria for intravenous alteplase in acute ischemic stroke: A statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 47:581–641Google Scholar

Emberson, J, Lee, KR, Lyden, P et al. (2014). Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischemic stroke: A meta-analysis of individual patient data from randomized trials. Lancet 384:1929–1935Google Scholar

Fletcher, AP, Alkjaersig, N, Lewis, M et al. (1976). A pilot study of urokinase therapy in cerebral infarction. Stroke 7:135–142Google Scholar

Furlan, A, Higashida, R, Wechsler, L et al. (1999). Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. Journal of the American Medical Association 282:2003–2011Google Scholar

Furlan, AJ, Eyding, D, Albers, GW et al. (2006). Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): Evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 37:1227–1231Google Scholar

Goyal, M, Demchuk, AM, Menon, BK et al. (2015). Randomized assessment of rapid endovascular treatment of ischemic stroke. New England Journal of Medicine 372:1019–1030Google Scholar

Goyal, M, Menon, BK, van Zwam, WH et al. (2016). Endovascular thrombectomy after large-vessel ischemic stroke: A meta-analysis of individual patient data from five randomized trials. Lancet 387:1723–1731Google Scholar

Gupta, R, Horev, A, Nguyen, T et al. (2013). Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomes. Journal of NeuroInterventional Surgery 5:294–297Google Scholar

Hacke, W, Kaste, M, Fieschi, C et al. (1995). Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Coorperative Acute Stroke Study (ECASS). JAMA 274:1017–1025Google Scholar

Hacke, W, Kaste, M, Fieschi, C et al. (1998). Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischemic stroke (ECASS II). Second European–Australasian Acute Stroke Study Investigators. Lancet 352:1245–1251Google Scholar

Hacke, W, Albers, G, Al-Rawi, Y et al. (2005). The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36:66–73Google Scholar

Haley, EC Jr., Levy, DE, Brott, TG et al. (1992). Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset. Stroke 23:641–645Google Scholar

Hankey, GJ, Norrving, B, Hacke, W et al. (2014). Management of acute stroke in patients taking novel oral anticoagulants. International Journal of Stroke 9:627–632Google Scholar

Hemmen, TM, Lyden, PD (2007). Induced hypothermia for acute stroke. Stroke 38:794–799Google Scholar

Hypothermia After Cardiac Arrest Study Group (2002). Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. New England Journal of Medicine 346:549–556Google Scholar

International Stroke Trial Collaborative Group (1997). The International Stroke Trial (IST): A randomised trial of aspirin subcutaneous heparin both or neither among 19435 patients with acute ischemic stroke. Lancet 349:1569–1581Google Scholar

IST-3 Collaborative Group (2012). The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischemic stroke [the third International Stroke Trial (IST-3)]: A randomized controlled trial. Lancet 379:2352–2363Google Scholar

IST-3 Collaborative Group (2015). Association between brain imaging signs, early and late outcomes, and response to intravenous alteplase after acute ischemic stroke in the third International Stroke Trial (IST-3): Secondary analysis of a randomized controlled trial. Lancet Neurology 14:485–496Google Scholar

Jauch, EC, Saver, JL, Adams, HP et al. (2013). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947Google Scholar

Jovin, TG, Chamorro, A, Cobo, E et al. (2015). Thrombectomy within 8 hours after symptom onset in ischemic stroke. New England Journal of Medicine. 372:2296–2306Google Scholar

Kidwell, CS, Jahan, R, Gornbein, J et al. (2013). A trial of imaging selection and endovascular treatment for ischemic stroke. New England Journal of Medicine 368:914–923Google Scholar

Krieger, DW, Yenari, MA (2004). Therapeutic hypothermia for acute ischemic stroke: What do laboratory studies teach us? Stroke 35:1482–1489Google Scholar

Lyden, PD, Madden, KP, Clark, WM et al. (1990). Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits. Stroke 21:1589–1593Google Scholar

Ma, QF, Chu, CB, Song, HQ (2015). Intravenous versus intra-arterial thrombolysis in ischemic stroke: A systematic review and meta-analysis. PLoS One 10:e0116120Google Scholar

Menon, BK, Saver, JL, Prabhakaran, S et al. (2012). Risk score for intracranial hemorrhage in patients with acute ischemic stroke treated with intravenous tissue-type plasminogen activator. Stroke 43:2293–2299Google Scholar

Meyer, JS, Gilroy, J, Barnhart, MI et al. (1963). Therapeutic thrombolysis in cerebral thromboembolism. Double-blind evaluation of intravenous plasmin therapy in carotid and middle cerebral arterial occlusion. Neurology 13:927–937Google Scholar

Muir, KW (2001). Magnesium for neuroprotection in ischemic stroke: Rationale for use and evidence of effectiveness. CNS Drugs 15:921–930Google Scholar

Multicenter Acute Stroke Trial – Europe Study Group (1996). Thrombolytic therapy with streptokinase in acute ischemic stroke. New England Journal of Medicine 335:145–150Google Scholar

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995). Tissue plasminogen activator for acute ischemic stroke. New England Journal of Medicine 333:1581–1588Google Scholar

Nogueira, RG, Lutsep, HL, Gupta, R et al. (2012). Trevo versus Merci retrievers for thrombectomy revascularization of large vessel occlusion in acute ischemic stroke (TREVO 2): A randomized trial. Lancet 38:1231–1240Google Scholar

Nogueira, RG, Jadhav, AP, Haussen, DC et al. (2018). Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct. New England Journal of Medicine 378:11–21Google Scholar

O’Donnell, MJ, Berge, E, Sandset, PM (2006). Are there patients with acute ischemic stroke and atrial fibrillation that benefit from low molecular weight heparin? Stroke 37:452–455Google Scholar

Parsons, M, Spratt, N, Bivard, A et al. (2012). A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. New England Journal of Medicine 366:1099–1107Google Scholar

Pierot, L, Soize, S, Benaissa, A et al. (2015). Techniques for endovascular treatment of acute ischemic stroke: From intra-arterial fibrinolytics to stent-retrievers. Stroke 46:909–914Google Scholar

Pollack, CV Jr., Reilly, PA, Eikelboom, J et al. (2015). Idarucizumab for dabigatran reversal. New England Journal of Medicine 373:511–520Google Scholar

Powers, WJ, Derdeyn, CP, Biller, J et al. (2015). 2015 American Heart Association/American Stroke Association focused updated of the 2013 guidelines for the early management of patients with acute ischemic stroke regarding endovascular treatment: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:3020–3035Google Scholar

Powers, WJ, Rabinstein, AA, Ackerson, T et al. (2018). Guidelines for the early management of patients with acute ischemic stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 49:e46–e110Google Scholar

Rothwell, PM, Algra, A, Chen, Z et al. (2016). Effects of aspirin on risk of severity of early recurrent stroke after transient ischemic attack and ischemic stroke: Time-course analysis of randomized trials. Lancet 388:365–375Google Scholar

Sandercock, P, Gubitz, G, Foley, P et al. (2003). Antiplatelet therapy for acute ischemic stroke. Cochrane Database of Systematic Reviews 2:CD000024Google Scholar

Saver, JL (2006). Time is brain-quantified. Stroke 37:263–266Google Scholar

Saver, JL, Jahan, R, Levy, EI et al. (2012). Solitaire flow restoration device versus the Merci Retriever in patients with acute ischemic stroke (SWIFT): A randomized, parallel-group, non-ineriority trial. Lancet 380:1241–1249Google Scholar

Saver, JL, Goyal, M, Bonafe, A et al. (2015a). Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke. New England Journal of Medicine 372:2285–2295Google Scholar

Saver, JL, Starkman, S, Eckstein, M et al. (2015b). Prehospital use of magnesium sulfate as neuroprotection in acute stroke. New England Journal of Medicine 372:528–536Google Scholar

Smith, WS, Sung, G, Starkman, S et al. (2005). Safety and efficacy of mechanical embolectomy in acute ischemic: Results of the MERCI trial. Stroke 35:1432–1438Google Scholar

Smith, WS, Sung, G, Saver, J et al. (2008). Mechanical thrombectomy for acute ischemic stroke: Final results of the Multi MERCI trial. Stroke 39:1205–1212Google Scholar

Sussman, BJ, Fitch, TS (1958). Thrombolysis with fibrinolysin in cerebral arterial occlusion. JAMA 167:1705–1709Google Scholar

Sutherland, BA, Minnerup, J, Balami, JS et al. (2012). Neuroprotection for ischemic stroke: Translation from the bench to the bedside. International Journal of Stroke 7:407–418Google Scholar

Tanswell, P, Modi, N, Combs, D et al. (2002). Pharmacokinetics and pharmacodynamics of tenecteplase in fibrinolytic therapy in acute myocardial infarction. Clinical Pharmacokinetics 41:1229Google Scholar

Tsivgoulis, G, Zand, R, Katsanos, AH et al. (2016). Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: A meta-analysis. JAMA Neurology 73:675–683Google Scholar

von Kummer, R, Mori, E, Truelsen, T et al. (2016). Desmoteplase 3 to 9 hours after major artery occlusion stroke: The DIAS-4 Trial (Efficacy and Safety Study of Desmoteplase to Treat Acute Ischemic Stroke). Stroke 47:2880–2887Google Scholar

Whiteley, WN, Emberson, JE, Lees, KR et al. (2016). Risk of intracerebral hemorrhage with alteplase after acute ischemic stroke: A secondary analysis of an individual patient data meta-analysis. Lancet Neurology 15:925–933Google Scholar

Wong, KS, Chen, C, Ng, PW et al. (2007). Low-molecular-weight heparin compared with aspirin for the treatment of acute ischemic stroke in Asian patients with large artery occlusive disease: A randomised study. Lancet Neurology 6:407–413Google Scholar

Yamaguchi, T, Mori, E, Minematsu, K et al. (2006). Alteplase at 0.6mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). Stroke 37:1810–1815Google Scholar

Yang, MH, Lin, HY, Fu, J et al. (2015). Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A systematic review and meta-analysis. The Surgeon 13:230–240Google Scholar

Zivin, JA, Fisher, M, DeGirolami, U et al. (1985). Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230:1289–1292Google Scholar

Ansell, JE, Bakhru, SH, Laulicht, BE et al. (2014). Use of PER977 to reverse the anticoagulant effect of edoxaban. New England Journal of Medicine 371:2141–2142Google Scholar

Ansell, JE, Laulicht, BE, Bakhru, SH et al. (2016). Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin. Thrombosis Research 146:113–118Google Scholar

Baharoglu, MI, Cordonnier, C, Salman, RA et al. (2016). Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral hemorrhage associated with antiplatelet therapy (PATCH): A randomized, open-label, phase 3 trial. Lancet 387:2605–2613Google Scholar

Bertram, M, Bonsanto, M, Hacke, W et al. (2000). Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. Journal of Neurology 247:209–214Google Scholar

Brisman, MH, Bederson, JB, Sen, CN et al. (1996). Intracerebral hemorrhage occurring remote from the craniotomy site. Neurosurgery 39:1114–1121Google Scholar

Chong, BH, Chan, KH, Pong, V et al. (2012). Use of aspirin in Chinese after recovery from primary intracerebral hemorrhage. Thrombosis and Hemostasis 107:241–247Google Scholar

Cohen, ZR, Ram, Z, Knoller, N et al. (2002). Management and outcome of non-traumatic cerebellar haemorrhage. Cerebrovascular Diseases 14:207–213Google Scholar

Connolly, SJ, Milling, TJ Jr., Eikelboom, JW et al. (2016). Andexanet alfa for acute major bleeding associated with factor Xa inhibitors. New England Journal of Medicine 375:1131–1141Google Scholar

Estol, CJ, Kase, CS (2003). Need for continued use of anticoagulants after intracerebral hemorrhage. Current Treatment Options in Cardiovascular Medicine 5:201–209Google Scholar

Friedman, JA, Pollock, BE, Nichols, DA et al. (2001). Results of combined stereotactic, radiosurgery and transarterial embolization for dural arteriovenous fistulas of the transverse and sigmoid sinuses. Journal of Neurosurgery 94:886–891Google Scholar

Gorelick, PB and Weisman, SM. (2005). Risk of hemorrhagic stroke with aspirin use: an update. Stroke 36:1801–1807Google Scholar

Greene, GM, Godersky, JC, Biller, J et al. (1990). Surgical experience with cerebral amyloid angiopathy. Stroke 21:1545–1549Google Scholar

Gregson, BA, Rowan, EN and Mendelow, AD (2013). Letter to the editor by Gregson et al. regarding article, “Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: A meta-analysis of randomized controlled trials.” Stroke 44:e45Google Scholar

Hanley, DF, Lane, K, McBee, N et al. (2017). Thrombolytic removal of intraventricular hemorrhage in treatment of severe stroke: Results of the randomized, multicenter, multiregion, placebo-controlled CLEAR III trial. Lancet 389:603–611Google Scholar

Hankey, GJ (2017). Stroke. Lancet 389:641–654Google Scholar

Hart, RG, Pearce, LA and Aguilar, MI. (2007) Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation. Annals of Internal Medicine 147:590–592Google Scholar

Heidbuchel, H, Verhamme, P, Alings, M et al. (2015). Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. Europace 17:1467–1507Google Scholar

Hemphill, JC III, Greenberg, SM, Anderson, CS et al. (2015). Guidelines for the management of spontaneous intracerebral hemorrhage: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 46:2032–2060Google Scholar

Horne, MA, Flemming, KD, Su, I-C et al. (2016). Clinical course of untreated cerebral cavernous malformations: A meta-analysis of individual patient data. Lancet Neurology 15:166–173Google Scholar

Izumihara, A, Ishihara, T, Iwamoto, N et al. (1999). Postoperative outcome of 37 patients with lobar intracerebral hemorrhage related to cerebral amyloid angiopathy. Stroke 30:29–33Google Scholar

Jensen, MB, St. Louis, EK (2005). Management of acute cerebellar stroke. Archives of Neurology 62:537–544Google Scholar

Kamel, H, Navi, BB, Nakagawa, K et al. (2011) Hypertonic saline versus mannitol for the treatment of elevated intracranial pressure: A meta-analysis of randomized clinical trials. Critical Care Medicine 39:554–559Google Scholar

Kawaguchi, S, Okuno, S, Sakaki, T (2000). Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. Journal of Neurosurgery 93:397–401Google Scholar

Kuramatsu, JB, Gerner, ST, Schellinger, PD et al. (2015). Anticoagulant reversal, blood pressure levels, and anticoagulant resumption in patients with anticoagulation-related intracerebral hemorrhage. JAMA 313:824–836Google Scholar

Leker, RR, Abramsky, O (1998). Early anticoagulation in patients with prosthetic heart valves and intracerebral hematoma. Neurology 50:1489–1491Google Scholar

McCarron, MO, Nicoll, JA, Love, S et al. (1999). Surgical intervention biopsy and APOE genotype in cerebral amyloid angiopathy-related haemorrhage. British Journal of Neurosurgery 13:462–467Google Scholar

Mendelow, AD, Gregson, BA, Fernandes, HM et al. (2005). Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral hematomas in the international Surgical Trial in Intracerebral Hemorrhage (STICH): A randomized trial. Lancet 365:387–397Google Scholar

Mendelow, AD, Gregson, BA, Rowan, EN et al. (2013). Early surgery versus initial conservative treatment in patients with spontaneous supratentorial lobar intracerebral hematomas (STITCH II): A randomized trial. Lancet 382:397–408Google Scholar

Menon, RS, Burgess, RE, Wing, JJ et al. (2012). Predictors of highly prevalent brain ischemia in intracerebral hemorrhage. Annals of Neurology 71:199–205Google Scholar

Mould, WA, Carhuapoma, JR, Muschelli, J et al. (2013). Minimally invasive surgery plus recombinant tissue-type plasminogen activator for intracerebral hemorrhage evacuation decreases perihematomal edema. Stroke 44:627–634Google Scholar

Moultrie, F, Horne, MA, Josephson, CB et al. (2014). Outcome after surgical or conservative management of cerebral cavernous malformations. Neurology 83:582–589Google Scholar

Muizelaar, JP, Marmarou, A, Ward, JD et al. (1991). Adverse effects of prolonged hyperventilation in patients with severe head injury: A randomized clinical trial. Journal of Neurosurgery 75:731–739Google Scholar

Naidech, AM, Liebling, SM, Rosenberg, NF et al. (2012). Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage. Neurocritical Care 16:82–87Google Scholar

Nishimoto, T, Yuki, K, Sasaki, T et al. (2005). A ruptured middle cerebral artery aneurysm originating from the site of anastomosis 20 years after extracranial-intracranial bypass for moyamoya disease: Case report. Surgical Neurology 64:261–265Google Scholar

O’Leary, S, Hodgson, TJ, Coley, SC et al. (2002). Intracranial dural arteriovenous malformations: Results of stereotactic radiosurgery in 17 patients. Clinical Oncology of the Royal College of Radiologists 14:97–102Google Scholar

Pan, DH, Chung, WY, Guo, WY et al. (2002). Stereotactic radiosurgery for the treatment of dural arteriovenous fistulas involving the transverse-sigmoid sinus. Journal of Neurosurgery 96:823–829Google Scholar

Phan, TG, Koh, M, Wijdicks, EFM (2000). Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Archives of Neurology 57:1710–1713Google Scholar

Pollack, CV Jr., Reilly, PA, Eikelboom, J et al. (2015). Idarucizumab for dabigatran reversal. New England Journal of Medicine 373:511–520Google Scholar

Qureshi, AI, Palesch, YY, Barsan, WG et al. (2016). Intensive blood-pressure lowering in patients with acute cerebral hemorrhage. New England Journal of Medicine 375:1033–1043Google Scholar

Rabinstein, AA, Tisch, SH, McClelland, RL et al. (2004). Cause is the main predictor of outcome in patients with pontine hemorrhage. Cerebrovascular Diseases 17:66–71Google Scholar

Samarasekera, N, Poorthuis, M, Kontoh, K et al. (2012). Guidelines for the Management of Cerebral Cavernous Malformations in Adults. London: Genetic Alliance UK and Cavernoma Alliance UK.Google Scholar

Schierhout, G and Roberts, I (2000). Hyperventilation therapy for acute traumatic brain injury. Cochrane Database of Systematic Reviews 2:CD000566Google Scholar

Steiner, T, Poli, S, Griebe, M et al. (2016). Fresh frozen plasma versus prothrombin complex concentrate in patients with intracerebral hemorrhage related to vitamin K antagonists (INCH): A randomized trial. Lancet 15:566–573Google Scholar

Stocchetti, N, Maas, AI, Chieregato, A et al. (2005). Hyperventilation in head injury: A review. Chest 127:1812–1827Google Scholar

Takeuchi, S, Wada, K, Nagatani, K et al. (2013). Decompressive hemicraniectomy for spontaneous intracerebral hemorrhage. Neurosurgical Focus 345:E5Google Scholar

Thompson, BB, Béjot, Y, Caso, V et al. (2010). Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology 75:1333–1342Google Scholar

Tomak, PR, Cloft, HJ, Kaga, A et al. (2003). Evolution of the management of tentorial dural arteriovenous malformations. Neurosurgery 52:750–760Google Scholar

Tsivgoulis, G, Katsanos, AH, Butcher, KS et al. (2014). Intensive blood pressure reduction in acute intracerebral hemorrhage: A meta-analysis. Neurology 83:1523–1529Google Scholar

Verheugt, FWA and Granger, GB (2015). Oral anticoagulants for stroke prevention in atrial fibrillation: current status, special situations, and unmet needs. Lancet 386:303–310Google Scholar

Wijdicks, EF, St. Louis, E (1997). Clinical profiles predictive of outcome in pontine hemorrhage. Neurology 49:1342–1346Google Scholar

Wijdicks, EFM, Schievink, WI, Brown, RD et al. (1998). The dilemma of discontinuation of anticoagulation therapy for patients with intracranial hemorrhage and mechanical heart valves. Neurosurgery 42:769–773Google Scholar

Wijdicks, EFM, Louis, EKS, Atkinson, JD et al. (2000). Clinician’s biases toward surgery in cerebellar hematomas: An analysis of decision-making in 94 patients. Cerebrovascular Diseases 10:93–96Google Scholar

Yasui, T, Komiyama, M, Iwai, Y et al. (2005). A brainstem cavernoma demonstrating a dramatic spontaneous decrease in size during follow-up: case report and review of the literature. Surgical Neurology 63:170–173Google Scholar

Yuan, ZH, Jiang, JK, Huang, WD et al. (2010). A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia. Journal of Clinical Neuroscience 17:685–693Google Scholar

Zhou, X, Chen, J, Li, Q et al. (2012). Minimally invasive surgery for spontaneous supratentorial intracerebral hemorrhage: a meta-analysis of randomized controlled trials. Stroke 43:2923–2930Google Scholar

Alexander, H, Bugge, C, Hagen, S (2001). What is the association between the different components of stroke rehabilitation and health outcomes? Clinical Rehabilitation 15:207–215Google Scholar

Allen, C, Glasziou, P, del Mar, C (1999). Bed rest: A potentially harmful treatment needing more careful evaluation. Lancet 354:1229–1233Google Scholar

Austin, MW, Ploughman, M, Glynn, L et al. (2014). Aerobic exercise effects on neuroprotection and brain repair following stroke: A systematic review and perspective. Neuroscience Research 87:8–15Google Scholar

AVERT Trial Collaboration Group (2015). Efficacy and safety of very early mobilization within 24 h of stroke onset (AVERT): A randomized controlled trial. Lancet 386:46–55Google Scholar

Bamford, J, Sandercock, PAG, Warlow, CP et al. (1989). Interobserver agreement for the assessment of handicap in stroke patients. Stroke 20:828Google Scholar

Bamford, J, Sandercock, PAG, Dennis, M et al. (1990). A prospective study of acute cerebrovascular disease in the community: The Oxfordshire Community Stroke Project 1981–86. 2. Incidence, case fatality rates and overall outcome at one year of cerebral infarction, primary intracerebral and subarachnoid haemorrhage. Journal Neurology, Neurosurgery and Psychiatry 53:16–22Google Scholar

Barber, PA, Demchuk, AM, Zhang, J et al. (2000). Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Program Early CT Score. Lancet 355:1670–1674Google Scholar

Baslow, MH (2003). N-acetylaspartate in the vertebrate brain: Metabolism and function. Neurochemical Research 28:941–953Google Scholar

Bayley, MT, Hurdowar, A, Teasell, R et al. (2007). Priorities for stroke rehabilitation and research: Results of a 2003 Canadian Stroke Network consensus conference. Archives of Physical and Medical Rehabilitation 88:526–528Google Scholar

Berkelbach van der Sprenkel, JW, Luyten, PR, van Rijen, PC et al. (1988). Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. Stroke 19:1556–1560Google Scholar

Bernhardt, J, Dewey, H, Thrift, A et al. (2004). Inactive and alone: Physical activity within the first 14 days of acute stroke unit care. Stroke 35:1005–1009Google Scholar

Bernhardt, J, Churilov, L, Ellery, F et al. (2016). Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT). Neurology 86:1–8Google Scholar

Blennerhassett, J, Dite, W (2004). Additional task-related practice improves mobility and upper limb function early after stroke: A randomised controlled trial. Australian Journal of Physiotherapy 50:219–224Google Scholar

Bowen, A, Hazelton, C, Pollock, A et al. (2013). Cognitive rehabilitation for spatial neglect following stroke. Cochrane Database and Systematic Reviews 7:CD00Google Scholar

Brady, MC, Kelly, H, Godwin, J et al. (2016). Speech and language therapy for aphasia following stroke. Cochrane Database of Systematic Reviews 6:CD000425Google Scholar

Brandstater, ME (2005). Stroke rehabilitation. In Physical Medicine and Rehabilitation: Principles and Practice, De Lisa, JA, Gans, BM, Walsh, NE (eds.), pp. 1165–1169. Philadelphia, PA: Lippincott Williams & WilkinsGoogle Scholar

Breitenstein, C, Grewe, T, Flöel, A et al. (2017). Intensive speech and language therapy in patients with chronic aphasia after stroke: A randomized, open-label, blinded-endpoint, controlled trial in a health-care setting. Lancet 389:1528–1538Google Scholar

Bruhn, H, Frahm, J, Gyngell, ML et al. (1989). Cerebral metabolism in man after acute stroke: New observations using localized proton NMR spectroscopy. Magnetic Resonance Medicine 9:126–131Google Scholar

Calautti, C, Naccarato, M, Jones, PS et al. (2007). The relationship between motor deficit and hemisphere activation balance after stroke: A 3T fMRI study. Neuroimage 34:322–331Google Scholar

Cao, Y, D’Olhaberriague, L, Vikingstad, EM et al. (1998). Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke 29:112–122Google Scholar

Cheng, B, Forkert, ND, Zavaglia, M et al. ( 2014 ). Influence of stroke infarct location on functional outcome measured by the modified Rankin Scale. Stroke 45:1695–1702Google Scholar

Chuang, KY, Wu, SC, Yeh, MC et al. (2005). Exploring the associations between longterm care and mortality rates among stroke patients. Journal of Nursing Research 13:66–74Google Scholar

Chung, CS, Pollock, A, Campbell, T et al. (2013). Cognitive rehabilitation for executive dysfunction in adults with stroke or other adult non-progressive acquired brain damage. Cochrane Database of Systematic Reviews 4:CD008391Google Scholar

Cho, SH, Kim, DG, Kim, DS et al. (2007). Motor outcome according to the integrity of the corticospinal tract determined by diffusion tensor tractography in the early stage of corona radiata infarct. Neuroscience Letters 426:123–127Google Scholar

Collen, FM, Wade, DT (1991). Residual mobility problems after stroke. International Disability Studies 13:12–15Google Scholar

Collen, FM, Wade, DT, Bradshaw, CM (1990). Mobility after stroke: Reliability of measures of impairment and disability. International Disability Studies 12:6–9Google Scholar

Collen, FM, Wade, DT, Robb, GF et al. (1991). The Rivermead Mobility Index: A further development of the Rivermead Motor Assessment. International Disability Studies 13:50–54Google Scholar

Collin, C, Wade, D (1990). Assessing motor impairment after stroke: A pilot reliability study. Journal of Neurology, Neurosurgery and Psychiatry 53:576–579Google Scholar

Cramer, SC, Nelles, G, Benson, RR et al. (1997). A functional MRI study of subjects recovered from hemiparetic stroke. Stroke 28:2518–2527Google Scholar

Cramer, SC, Crafton, KR (2006). Somatotopy and movement representation sites following cortical stroke. Experimental Brain Research 168:25–32Google Scholar

Crinion, JT, Leff, AP (2015). Using functional imaging to understand therapeutic effects in poststroke aphasia. Current Opinions in Neurology 28:330–337Google Scholar

de Haan, R, Aaronson, N, Limburg, M et al. (1993). Measuring quality of life in stroke. Stroke 24:320–327Google Scholar

Delcourt, C, Sato, S, Zhang, S et al. (2017). Intracerebral hemorrhage location and outcome among INTERACT2 participants. Neurology 88:1408–1414Google Scholar

Dennis, M, Wellwood, I, Warlow, C (1997a). Are simple questions a valid measure of outcome after stroke? Cerebrovascular Diseases 7:22–27Google Scholar

Dennis, M, Wellwood, I, O’Rourke, S et al. (1997b). How reliable are simple questions in assessing outcome after stroke? Cerebrovascular Diseases 7:19–21Google Scholar

Dorman, P, Slattery, J, Farrell, B et al. (1998). Qualitative comparison of the reliability of health status assessments with the EuroQol and SF-36 questionnaires after stroke. Stroke 29:63–68Google Scholar

Dromerick, AW, Lang, CE, Birkenmeier, RL et al. (2009). Very Early Constraint-Induced Movement during Stroke Rehabilitation (VECTORS). Neurology 73:195–201Google Scholar

Dvorak, EM, Ketchum, NC, McGuire, JR (2011). The underutilization of intrathecal baclofen in poststroke spasticity. Topics in Stroke Rehabilitation 18:195–202Google Scholar

Early Supported Discharge Trialists (2005). Services for reducing duration of hospital care for acute stroke patients. Cochrane Database of Systematic Reviews 1:CD000443Google Scholar

Egan, K, Janssen, H, Sena, E et al. (2014). Exercise reduces infarct volume and facilitates neurobehavioral recovery: A systematic review and meta-analysis of exercise models in ischemic stroke. Neurorehabilitation and Neural Repair 28:800–812Google Scholar

Elsner, B, Kugler, J, Pohl, M et al. (2016). Transcranial direct current stimulation (tDCS) for improving activities of daily living, and physical and cognitive functioning, in people with stroke. Cochrane Database of Systematic Reviews 3:CD009645Google Scholar

Elsner, B, Kugler, J, Pohl, M et al. (2015). Transcranial direct current stimulation (tDCS) for improving aphasia in patients with aphasia after stroke. Cochrane Database of Systematic Reviews 5:CD009760Google Scholar

Enderby, PM, Wood, VA, Wade, DT et al. (1986). The Frenchay Aphasia Screening Test: A short simple test for aphasia appropriate for non-specialists. International Rehabilitation Medicine 8:166–170Google Scholar

Federico, F, Simone, IL, Lucivero, V et al. (1998). Prognostic value of proton magnetic resonance spectroscopy in ischemic stroke. Archives of Neurology 55:489–494Google Scholar

Foley, N, Bhogal, S, Foley, N (2006). Painful hemiplegic shoulder. In Canadian Stroke Network Evidence-Based Reviews of Stroke Rehabilitation http://ebrsrcom/index_homehtml (accessed 10 May 2007)Google Scholar

Ford, CC, Griffey, RH, Matwiyoff, NA et al. (1992). Multivoxel 1H-MRS of stroke. Neurology 42:1408–1412Google Scholar

Gerloff, C, Bushara, K, Sailer, A et al. (2006). Multimodal imaging of brain reorganization in motor areas of the contralesional hemisphere of well recovered patients after capsular stroke. Brain 129:791–808Google Scholar

Gracies, JM, Brashear, A, Jech, R et al. (2015). Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: A double-blind randomized controlled trial. Lancet Neurology 14:992–1001Google Scholar

Gustafsson, L, McKenna, K (2006). A programme of static positional stretches does not reduce hemiplegic shoulder pain or maintain shoulder range of motion: A randomized controlled trial. Clinical Rehabilitation 20:277Google Scholar

Hamdy, S, Aziz, Q, Rothwell, JC et al. (1998). Recovery of swallowing after dysphagic stroke relates to functional reorganization in the intact motor cortex. Gastroenterology 115:1104–1112Google Scholar

Hand, PJ, Kwan, J, Lindley, RI et al. (2006). Distinguishing between stroke and mimic at the bedside: The brain attack study. Stroke 37:769–775Google Scholar

Hsu, WY, Cheng, CH, Liao, KK et al. (2012). Effects of repetitive transcranial magnetic stimulation on motor functions in patients with stroke: A meta-analysis. Stroke 43:1849–1857Google Scholar

Jang, SH (2010) Prediction of motor outcome for hemiparetic stroke patients using diffusion tensor imaging: A review. NeuroRehabilitation 27:367–372Google Scholar

Jehkonen, M, Ahonen, JP, Dastidar, P et al. (1998). How to detect visual neglect in acute stroke. Lancet 351:727–728Google Scholar

Johnston, KC, Wagner, DP, Wang, XQ et al. (2007). Validation of an acute ischemic stroke model: Does diffusion-weighted imaging lesion volume offer a clinically significant improvement in prediction of outcome? Stroke 38:1820–1825Google Scholar

Kalladka, D, Sinden, J, Pollock, K et al. (2016). Human neural stem cells in patients with chronic ischemic stroke (PISCES): A phase 1, fist-in-man study. Lancet 388:787–796Google Scholar

Krakauer, JW, Carmichael, ST, Corbett, D et al. (2012). Getting neurorehabilitation right: What can be learned from animal models? Neurorehabilitaiton and Neural Repair 26:923–931Google Scholar

Kreisel, SH, Hennerici, MG, Bazner, H (2007). Pathophysiology of stroke rehabilitation: The natural course of clinical recovery, use-dependent plasticity and rehabilitative outcome. Cerebrovascular Diseases 23:243–255Google Scholar

Kwakkel, G (2006). Impact of intensity of practice after stroke: Issues for consideration. Disability and Rehabilitation 28:823–830Google Scholar

Kwakkel, G, van Peppen, R, Wagenaar, RC et al. (2004). Effects of augmented exercise therapy time after stroke: A meta-analysis. Stroke 35:2529–2536Google Scholar

Kwon, YH, Lee, MY, Park, JW et al. (2007). Differences of cortical activation pattern between cortical and corona radiata infarct. Neuroscience Letters 417:138–142Google Scholar

Langhorne, P, Dennis, MS (2004). Stroke units: The next 10 years. Lancet 363:834–835Google Scholar

Langhorne, P, Duncan, P (2001). Does the organization of postacute stroke care really matter? Stroke 32:268–274Google Scholar

Langhorne, P, Holmqvist, LW (2007). Early Supported Discharge Trialists. Early supported discharge after stroke. Journal of Rehabilitation Medicine 39:103–108Google Scholar

Langhorne, P, Wagenaar, R, Partridge, C (1996). Physiotherapy after stroke: More is better? Physiotherapy Research International 1:75–88Google Scholar

Langhorne, P, Stott, D, Robertson, L et al. (2000). Medical complications after stroke: A multicenter study. Stroke 31:1223–1229Google Scholar

Langton Hewer, R (1990). Rehabilitation after stroke. Quarterly Journal of Medicine 76:659–674Google Scholar

Laver, KE, George, S, Thoomas, S et al. (2015). Virtual reality for stroke rehabilitation. Cochrane Database of Systematic Reviews 10:CD008349Google Scholar

Legg, LA, Drummond, AE, Langhorne, P (2006). Occupational therapy for patients with problems in activities of daily living after stroke. Cochrane Database of Systematic Reviews 4:CD0030585Google Scholar

Legh-Smith, J, Wade, DT, Langton-Hewer, R (1986). Services for stroke patients one year after stroke. Journal of Epidemiology Community Health 40:161–165Google Scholar

Lindenberg, R, Renga, V, Zhu, LL et al. (2010). Structural integrity of corticospinal motor fibers predicts motor impairment in chronic stroke. Neurology 74:280–287Google Scholar

Lindenberg, R, Zhu, LL, Rüber, T et al. (2012). Predicting functional motor potential in chronic stroke patients using diffusion tensor imaging. Human Brain Mapping 33:1040–1051Google Scholar

Liu, N, Cadilhac, DA, Andrew, NE et al. (2014). Randomized controlled trial of early rehabilitation after intracerebral hemorrhage: Difference in outcomes within 6 months of stroke. Stroke 45:3502–3507Google Scholar

Loetscher, T, Lincoln, NB (2013). Cognitive rehabilitation for attention deficits following stroke. Cochrane Database of Systematic Reviews 5:CD002842Google Scholar

Loubinoux, I, Dechaumont-Palacin, S, Castel-Lacanal, E et al. (2007). Prognostic value of fMRI in recovery of hand function in subcortical stroke patients. Cerebral Cortex 17:2980–2987Google Scholar

Lyden, PD, Hantson, L (1998). Assessment scales for the evaluation of stroke patients. Journal of Stroke and Cerebrovascular Diseases 7:113–127Google Scholar

Lundström, E, Terént, A, Borg, J (2008). Prevalence of disability spasticity 1year after first-event stroke. European Journal of Neurology 15:533–539Google Scholar

Lyle, RC (1981). A performance test for assessment of upper limb function in physical rehabilitation treatment and research. International Journal of Rehabilitation Research 4:483–492Google Scholar

Lynch, E, Hillier, S, Cadilhac, D (2014). When should physical rehabilitation commence after stroke: A systematic review. International Journal of Stroke 9:468–478Google Scholar

Mead, GE, Hsieh, CF, Lee, R et al. (2012). Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery. Cochrane Database of Systematic Reviews 11:CD009286Google Scholar

Mehrholz, J, Pohl, M, Elsner, B (2014). Treadmill training and body weight support for walking after stroke. Cochrane Database of Systematic Reviews 1:CD002840Google Scholar

Mehrholz, J, Pohl, M, Platz, T et al. (2015). Electromechanical and robot-assisted arm training for improving activities of daily living, arm function, and arm muscle strength after stroke. Cochrane Database of Systematic Reviews 11:CD006876Google Scholar

Mehrholz, J, Thomas, S, Werner, C et al. (2017). Electromechanical-assisted training for walking after stroke. Cochrane Database of Systematic Reviews 5:CD006185Google Scholar

Meyer, S, Kessner, SS, Cheng, B et al. (2016). Voxel-based lesion-symptom mapping of stroke lesions underlying somatosensory deficits. NeuroImage: Clinical 10:257–266Google Scholar

Mitchell, C, Bowen, A, Tyson, S et al. (2017). Interventions for dysarthria due to stroke and other adult-acquired, non-progressive brain injury. Cochrane Database of Systematic Reviews 1:CD002088Google Scholar

Murase, N, Duque, J, Mazzocchio, R et al. (2004). Influence of interhemispheric interactions on motor function in chronic stroke. Annals of Neurology 55:400–409Google Scholar